We Can Medicines Co., Ltd.

Research We Can Medicines Co., Ltd. (6929.TWO) on Bullrun: market cap TWD 987.47M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 987.47M.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 987.47Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About We Can Medicines Co., Ltd.

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is We Can Medicines Co., Ltd.'s market cap?

We Can Medicines Co., Ltd.'s market capitalization is TWD 987.47M.

What does We Can Medicines Co., Ltd. do?

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.